Mental disorders and health {#cesec10}
===========================

Using data from a Danish population-based cohort, [Natalie Momen](https://dx.doi.org/10.1056/NEJMoa1915784){#interrefs10} and colleagues estimated the risk of developing subsequent medical conditions in people with a mental disorder. The cohort included 5 940 299 people (n=698 874 with a mental disorder), followed up for 83·9 million person-years. Analysis showed that there was an overall increased risk for developing a medical condition in people with a mental disorder (median hazard ratio \[HR\] 1·37 \[IQR 1·20--1·55\]). The greatest risk noted was for developing a urogenital condition in people with an eating disorder (HR 3·62 \[3·11--4·22\]). The authors highlighted that the risks for developing a medical condition varied with time from diagnosis of a mental disorder.

Helpful treatment for depression {#cesec20}
================================

With data from 16 countries included in the WHO World Mental Health surveys (n=80 332), Meredith Harris and colleagues examined the perceived helpfulness of treatment for people with major depressive disorder. Survey responses showed that 2726 individuals had ever received treatment for major depressive disorder that they perceived as helpful. After seeing ten professionals after previous unhelpful treatment, the cumulative probability of receiving treatment perceived as helpful was 93·9% (SE 1·2). However, the cumulative probability of seeking help from ten professionals was 21·5% (SE 3·2). The [authors](https://dx.doi.org/10.1001/jamapsychiatry.2020.1107){#interrefs20} noted that a shorter delay in starting treatment and receiving treatment from a mental health professional were both associated with persistence in seeking treatment.

COVID-19 and health-care worker mental health {#cesec30}
=============================================

In a [rapid review and meta-analysis](https://dx.doi.org/10.1136/bmj.m1642){#interrefs30}, Steve Kisely and colleagues highlighted the importance of the psychological wellbeing of health-care workers during emerging virus outbreaks. The meta-analysis of 25 studies included reports of severe acute respiratory syndrome, coronavirus disease 2019, Middle East respiratory syndrome, Ebola virus disease, influenza A virus subtype H1N1, and influenza A virus subtype H7N9. Results indicated that relative to controls with lower exposure, health-care workers in contact with patients affected by a virus outbreak had a greater burden of acute or post-traumatic stress (odds ratio 1·71 \[95% CI 1·28--2·29; I^2^=44%) and psychological distress (1·74 \[1·50--2·03\]; 17%). Protective factors included older age, greater experience, provision of protective equipment, a supportive work environment, and having access to psychological support.

CBT for health anxiety {#cesec40}
======================

In a randomised non-inferiority [trial](https://dx.doi.org/10.1001/jamapsychiatry.2020.0940){#interrefs40}, Erland Axelsson and colleagues compared 12 weeks of internet-delivered cognitive behavioural therapy (CBT) with face-to-face CBT for primary care patients with health anxiety (n=204). Analysis was done using a non-inferiority margin of 2·25 points on the Health Anxiety Inventory. After 12 weeks of treatment, internet-delivered CBT showed non-inferiority to face-to-face CBT for patients with health anxiety in both intention-to-treat analysis (B=0·00 \[95% CI upper limit 1·98\]; Cohen *d*=0·00 \[0·23\]) and the per-protocol analysis (0·01 \[2·17\]; 0·00 \[0·25\]). The authors highlighted that the net societal cost was lower for internet-delivered CBT than individual face-to-face CBT (treatment period point difference: USD \$3854).

Genes, environment, and schizophrenia {#cesec50}
=====================================

With data from the Danish iPSYCH sample (n=19 746; 2636 cases of schizophrenia), Kristine Engemann and colleagues [examined genetic and environmental associations](https://dx.doi.org/10.1093/schbul/sbaa058){#interrefs50} for developing schizophrenia. Participants were born between 1981--2005, with schizophrenia diagnosis made between 1994--2012 at age 10 years or older. Green space exposure was quantified using the normalised difference vegetation index (NDVI) up to the age of 10 years. Analysis suggested that childhood exposure to greater green space was associated with a lower risk of developing schizophrenia (decrease in risk for a 1 unit increase in NDVI: adjusted HR 0·52 \[95% CI 0·40--0·66\]). A higher schizophrenia polygenic risk score was associated with greater risk for developing schizophrenia (increase in risk for a 1 SD increase in score: 1·24 \[95% CI 1·18--1·30\]). Both factors were independently associated with schizophrenia risk with evidence of a dose-response relation and there was no evidence for interaction between the two factors.

Risks of antenatal corticosteroids {#cesec60}
==================================

In a Finnish population-based retrospective cohort study, Katri Räikkönen and colleagues [assessed](https://dx.doi.org/10.1001/jama.2020.3937){#interrefs60} associations between antenatal corticosteroid treatment and mental and behavioural disorders in childhood. Participants included 14 868 corticosteroid treatment-exposed children and 655 229 unexposed children, followed-up for a median of 5·8 years (IQR 3·1--8·7). The risk of mental and behavioural disorders in childhood was higher in the exposed cohort compared with the unexposed cohort (adjusted HR 1·33 \[95% CI 1·26--1·41\]; p\<0·001), and also when only term born children were considered (HR 1·47 \[95% CI 1·36--1·69\]; p\<0·001). Although the cumulative incidence rate of mental and behavioural disorders in childhood was higher in exposed preterm born children versus unexposed counterparts, the HR was not significant (HR 1·00 \[95% CI 0·92--1·09\]; p=0·97).
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